FDA warns consumers about Liqiang 4 capsules
Fri, 01 Jul 2005 11:22 PM EST
... WASHINGTON (Reuters) - The U.S. Food and Drug Administration warned consumers on Friday not to take Liqiang 4 dietary supplement capsules, which contain a drug that could have life-threatening consequences for some users. ...
Related Topics
- Brompheniramine and Pseudoephedrine Extended Release
- Fenofibrate Capsules
- Cyanocobalamin Capsules
- Casanthranol and Docusate Sodium
- Sulfinpyrazone Capsules
- Nizatidine capsules
- Cromolyn Inhalation Capsules
- Vancomycin Capsules
- Tacrolimus ointment
- Clindamycin Capsules
- Calcium Acetate Capsules or Gelcaps
- Mammography
- Carcinogens
- Maggie Drozd Spice Capsules
- Tetracycline Tablets or Capsules
- Ganciclovir Oral
- Pimecrolimus Cream 1%
- Chlorpromazine Extended-Release Capsules
- Dietary Guidelines
- Thalidomide

Not Signed In -


